摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

acetic acid (3,5-dibromo-2,4-dihydroxy-benzylidene)-hydrazide | 1147839-88-0

中文名称
——
中文别名
——
英文名称
acetic acid (3,5-dibromo-2,4-dihydroxy-benzylidene)-hydrazide
英文别名
——
acetic acid (3,5-dibromo-2,4-dihydroxy-benzylidene)-hydrazide化学式
CAS
1147839-88-0
化学式
C9H8Br2N2O3
mdl
——
分子量
351.982
InChiKey
ULSBJQOZEWDCET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    246-248 °C
  • 密度:
    2.01±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.09
  • 重原子数:
    16.0
  • 可旋转键数:
    2.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    81.92
  • 氢给体数:
    3.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3,5-二溴-2,4-二羟基苯甲醛乙酰肼乙醇 为溶剂, 反应 3.0h, 以86.3%的产率得到acetic acid (3,5-dibromo-2,4-dihydroxy-benzylidene)-hydrazide
    参考文献:
    名称:
    Discovering Potent Inhibitors Against the β-Hydroxyacyl-Acyl Carrier Protein Dehydratase (FabZ) of Helicobacter pylori: Structure-Based Design, Synthesis, Bioassay, and Crystal Structure Determination
    摘要:
    The discovery of HpFabZ inhibitors is now of special interest in the treatment of various gastric diseases. In this work, three series of derivatives (compounds 3, 4, and 5) were designed, synthesized, and their biological activities were investigated as potential HpFabZ inhibitors in a two phased manner. First, we designed and synthesized two series of derivatives (3a-r and 4a-u) and evaluated the enzyme-based assay against HpFabZ. Five compounds (3i-k, 3m, and 3q) showed potential inhibitory activity, with IC(50) values less than 2 muM. Second, a focused combinatorial library containing 280 molecules was designed employing the LD1.0 program. Twelve compounds (5a-l) were selected and synthesized. The activity of the most potent compound 5h (IC(50) = 0.86 muM) was 46 times higher than that of the hit 1. The high hit rate and the potency of the new HpFabZ inhibitors demonstrated the efficiency of the strategy for the focused library design and virtual screening.
    DOI:
    10.1021/jm8015602
点击查看最新优质反应信息